Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia.
From a cohort of 35 patients with hereditary haemorrhagic telangiectasia (HHT), 12 patients have undergone closure of the one or both nasal cavities during the last three years for refractory epistaxis. All had failed other forms of treatment including hormone therapy, laser coagulation and septodermoplasty. All patients were available for follow-up at six months or longer. In all patients where complete closure was achieved (11 out of 12) bleeding ceased completely from the operated side.
Lund
V J
VJ
Institute of Laryngology and Otology, London, UK.
Howard
D J
DJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004844:Epistaxis / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009296:Nasal Cavity / Q000601:surgery*; D012008:Recurrence; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000601:surgery*